Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Conavi Med Corp (CNVIF)

Conavi Med Corp (CNVIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Conavi Med Corp 76 Berkeley Street TORONTO A6 M5A 2W7 CAN

www.titanmedicalinc.com P: 416-548-7522

Sector:

Medical

INDUSTRY GROUPING:

Medical Instruments

Description:

Conavi Medical Corp. is focused on designing, manufacturing and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid(TM) System is the first system to combine both intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in TORONTO.

Key Statistics

Overview:

Market Capitalization, $K 24,023
Enterprise Value, $K 21,003
Shares Outstanding, K 76,750
Float, K 76,735
% Float 99.98%
Short Interest, K 19
Short Float 0.02%
Days to Cover 1.00
Short Volume Ratio 0.80
% of Insider Shareholders 0.02%
% of Institutional Shareholders 0.03%

Financials:

Annual Sales, $ 6,520 K
Annual Net Income, $ -14,670 K
Last Quarter Sales, $ 160 K
Last Quarter Net Income, $ -1,940 K
EBIT, $ -6,830 K
EBITDA, $ -1,730 K

Growth:

1-Year Return -26.28%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -67.40%
5-Year Earnings Growth 48.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 12/29/25
Next Earnings Date 03/02/26
Earnings Per Share ttm -0.21
EPS Growth vs. Prev Qtr 66.67%
EPS Growth vs. Prev Year 76.92%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CNVIF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -132.52%
Profit Margin % -225.00%
Debt/Equity 0.00
Price/Sales 3.54
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.11
Interest Coverage 0.00
60-Month Beta 0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar